Symbols / ENSC Stock $0.36 -5.64% Ensysce Biosciences, Inc.

Healthcare • Biotechnology • United States • NCM
ENSC (Stock) Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
Stock Fundamentals
Scroll to Statements
Index EQUITY
Sector Healthcare
Industry Biotechnology
CEO Dr. D. Lynn Kirkpatrick Ph.D.
Exch · Country NCM · United States
Market Cap 3.35M
Enterprise Value -980.54K
Income -10.18M
Sales 5.07M
FCF (ttm) —
Book/sh 0.70
Cash/sh 0.47
Employees 8
Insider 10d —
IPO Mar 14, 2018
Div forward ($/yr)
Div TTM ($/yr)
Dividend Yield
Ex-Div Date
5Y Avg Yield
Yield vs 5Y Avg
Payout 0.00%
P/E —
Forward P/E -0.16
PEG —
P/S 0.66
P/B 0.51
P/C —
EV/EBITDA 0.10
EV/Sales -0.19
Quick Ratio 1.04
Current Ratio 1.59
Debt/Eq 10.63
LT Debt/Eq —
EPS (ttm) —
EPS next Y -2.23
EPS Growth —
Revenue Growth 44.40%
EPS Gr Q/Q —
Rev Gr Q/Q —
Earnings (next) 2026-03-30
Earnings (prior) 2026-03-30
ROA -98.10%
ROE -3.25%
ROIC —
Gross Margin -104.81%
Oper. Margin -147.79%
Profit Margin -200.84%
Shs Outstand —
Shs Float 9.27M
Insider Own 0.11%
Instit Own 4.98%
Short Float 0.69%
Short Ratio 0.09
Short Interest 64.30K
52W High 3.23
vs 52W High -88.80%
52W Low 0.31
vs 52W Low 15.06%
Beta 1.14
Impl. Vol. —
Rel Volume 0.04
Avg Volume 6.16M
Volume 247.41K
Target (mean) $16.45
Tgt Median $16.45
Tgt Low $16.45
Tgt High $16.45
# Analysts 1
Recom None
Prev Close $0.38
Price $0.36
Change -5.64%
About

No company description available for this symbol.

Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
—
Mean price target
2. Current target
—
Latest analyst target
3. DCF / Fair value
$16.45
Proxy: analyst mean price target (no FCF/EPS data available).
Ratings
Current target
—
Low
—
High
—
Mean
—
News
RSS: Latest ENSC news
Insider Transactions

No recent insider transactions.

Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Revenue
0.00
0.00
0.00
0.00
Operating Revenue
0.00
0.00
0.00
0.00
Operating Expense
10.24
+52.17%
6.73
-37.21%
10.72
-55.75%
24.22
Research And Development
10.38
+43.74%
7.22
-4.85%
7.59
-61.75%
19.84
Selling General And Administration
4.93
+4.45%
4.72
-11.95%
5.36
-22.41%
6.91
General And Administrative Expense
4.93
+4.45%
4.72
-11.95%
5.36
-22.41%
6.91
Other Gand A
4.93
+4.45%
4.72
-11.95%
5.36
-22.41%
6.91
Other Operating Expenses
-5.07
+2.75%
-5.21
-133.58%
-2.23
+11.61%
-2.52
Total Expenses
10.24
+52.17%
6.73
-37.21%
10.72
-55.75%
24.22
Operating Income
-10.24
-52.17%
-6.73
+37.21%
-10.72
+55.75%
-24.22
Total Operating Income As Reported
-10.24
-52.17%
-6.73
+37.21%
-10.72
+55.75%
-24.22
EBITDA
-10.15
-51.58%
-6.70
+34.81%
-10.27
+57.37%
-24.10
Normalized EBITDA
-10.15
-51.58%
-6.70
+34.81%
-10.27
+57.37%
-24.10
Reconciled Depreciation
0.01
0.00
—
0.00
EBIT
-10.16
-51.68%
-6.70
+34.81%
-10.27
+57.37%
-24.10
Total Unusual Items
—
—
0.43
-92.52%
5.76
Total Unusual Items Excluding Goodwill
—
—
0.43
-92.52%
5.76
Special Income Charges
—
—
0.15
-91.83%
1.79
Other Special Charges
—
—
-0.15
+91.83%
-1.79
Net Income
-10.18
-27.40%
-7.99
+24.74%
-10.61
+56.09%
-24.17
Pretax Income
-10.18
-27.41%
-7.99
+24.84%
-10.63
+56.10%
-24.21
Net Non Operating Interest Income Expense
-0.02
+98.55%
-1.29
-264.59%
-0.35
+92.90%
-4.98
Interest Expense Non Operating
0.02
-98.55%
1.29
+264.59%
0.35
+223.16%
0.11
Net Interest Income
-0.02
+98.55%
-1.29
-264.59%
-0.35
+92.90%
-4.98
Interest Expense
0.02
-98.55%
1.29
+264.59%
0.35
+223.16%
0.11
Other Income Expense
0.08
+148.82%
0.03
-92.47%
0.45
-91.08%
5.00
Other Non Operating Income Expenses
0.08
+148.82%
0.03
-92.47%
0.45
-91.08%
5.00
Gain On Sale Of Security
—
—
0.28
-95.07%
5.76
Tax Rate For Calcs
0.00
0.00
0.00
0.00
Tax Effect Of Unusual Items
0.00
0.00
0.00
0.00
Net Income Including Noncontrolling Interests
-10.18
-27.41%
-7.99
+24.84%
-10.63
+56.10%
-24.21
Net Income From Continuing Operation Net Minority Interest
-10.18
-27.40%
-7.99
+24.74%
-10.61
+56.09%
-24.17
Net Income From Continuing And Discontinued Operation
-10.18
-27.40%
-7.99
+24.74%
-10.61
+56.09%
-24.17
Net Income Continuous Operations
-10.18
-27.41%
-7.99
+24.84%
-10.63
+56.10%
-24.21
Minority Interests
0.00
+558.11%
0.00
-99.44%
0.01
-62.70%
0.04
Normalized Income
-10.18
-27.40%
-7.99
+24.74%
-10.61
+56.09%
-24.17
Net Income Common Stockholders
-10.18
-27.40%
-7.99
+24.83%
-10.63
+57.64%
-25.09
Otherunder Preferred Stock Dividend
0.00
-100.00%
0.00
-97.76%
0.01
-98.58%
0.91
Diluted EPS
-3.98
+65.24%
-11.45
+83.74%
-70.40
+96.63%
-2,091.60
Basic EPS
-3.98
+65.24%
-11.45
+83.74%
-70.40
+96.63%
-2,091.60
Basic Average Shares
2.56
+88.58%
1.36
+798.24%
0.15
+323.59%
0.04
Diluted Average Shares
2.56
+88.58%
1.36
+798.24%
0.15
+323.59%
0.04
Diluted NI Availto Com Stockholders
-10.18
-27.40%
-7.99
+24.83%
-10.63
+57.64%
-25.09
Total Other Finance Cost
—
—
—
4.88
Line Item Trend 2024-12-31 2023-12-31
Total Assets
5.60
+106.69%
2.71
Current Assets
5.34
+133.51%
2.29
Cash Cash Equivalents And Short Term Investments
3.50
+211.68%
1.12
Cash And Cash Equivalents
3.50
+211.68%
1.12
Receivables
0.12
+27.22%
0.10
Other Receivables
0.12
+27.22%
0.10
Prepaid Assets
1.70
+62.00%
1.05
Other Current Assets
0.02
+0.00%
0.02
Total Non Current Assets
0.25
-39.76%
0.42
Net PPE
0.00
0.00
Other Non Current Assets
0.25
-39.76%
0.42
Total Liabilities Net Minority Interest
2.22
-34.00%
3.36
Current Liabilities
2.21
-33.78%
3.33
Payables And Accrued Expenses
1.91
-23.11%
2.48
Payables
1.36
-29.90%
1.94
Accounts Payable
1.36
-29.90%
1.94
Current Accrued Expenses
0.55
+1.14%
0.54
Pensionand Other Post Retirement Benefit Plans Current
—
—
Current Debt And Capital Lease Obligation
0.30
-64.71%
0.85
Current Debt
0.30
-64.71%
0.85
Other Current Borrowings
0.30
-64.71%
0.85
Current Capital Lease Obligation
—
0.00
Current Deferred Liabilities
—
—
Current Deferred Revenue
—
—
Total Non Current Liabilities Net Minority Interest
0.01
-61.74%
0.03
Long Term Debt And Capital Lease Obligation
—
—
Long Term Debt
—
—
Other Non Current Liabilities
—
—
Stockholders Equity
3.71
+1248.62%
-0.32
Common Stock Equity
3.71
+1248.62%
-0.32
Capital Stock
0.00
+547.62%
0.00
Common Stock
0.00
+547.62%
0.00
Preferred Stock
0.00
0.00
Share Issued
1.36
+546.40%
0.21
Ordinary Shares Number
1.36
+546.41%
0.21
Treasury Shares Number
0.00
+20.00%
0.00
Additional Paid In Capital
133.25
+9.91%
121.23
Retained Earnings
-129.54
-6.57%
-121.56
Minority Interest
-0.33
-0.02%
-0.33
Total Equity Gross Minority Interest
3.38
+618.98%
-0.65
Total Capitalization
3.71
+1248.62%
-0.32
Working Capital
3.14
+400.50%
-1.04
Invested Capital
4.01
+654.00%
0.53
Total Debt
0.30
-64.71%
0.85
Net Debt
—
—
Capital Lease Obligations
—
0.00
Net Tangible Assets
3.71
+1248.62%
-0.32
Tangible Book Value
3.71
+1248.62%
-0.32
Derivative Product Liabilities
0.01
-61.74%
0.03
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Operating Cash Flow
-7.81
-4.05%
-7.50
+30.40%
-10.78
+39.73%
-17.89
Cash Flow From Continuing Operating Activities
-7.81
-4.05%
-7.50
+30.40%
-10.78
+39.73%
-17.89
Net Income From Continuing Operations
-10.18
-27.41%
-7.99
+24.84%
-10.63
+56.10%
-24.21
Depreciation Amortization Depletion
0.01
0.00
—
0.00
Depreciation
0.01
0.00
—
0.00
Depreciation And Amortization
0.01
0.00
—
0.00
Other Non Cash Items
0.68
-45.12%
1.24
+260.11%
0.34
-95.84%
8.29
Stock Based Compensation
0.18
+59.94%
0.11
-87.41%
0.88
-17.98%
1.07
Operating Gains Losses
-0.01
+38.03%
-0.02
+94.26%
-0.28
+95.78%
-6.74
Gain Loss On Investment Securities
-0.01
+38.03%
-0.02
+94.26%
-0.28
+95.78%
-6.73
Unrealized Gain Loss On Investment Securities
—
0.00
+100.00%
-0.15
+91.83%
-1.79
Change In Working Capital
1.52
+278.01%
-0.85
+10.12%
-0.95
-117.28%
5.48
Change In Receivables
-0.30
-1015.58%
-0.03
-114.81%
0.18
+8.71%
0.16
Change In Prepaid Assets
-0.44
-74.06%
-0.25
-118.10%
1.39
-15.77%
1.65
Change In Payables And Accrued Expense
2.25
+492.87%
-0.57
+77.26%
-2.52
-168.73%
3.66
Change In Accrued Expense
0.43
+6909.26%
0.01
+100.48%
-1.28
-225.72%
1.02
Change In Payable
1.82
+413.62%
-0.58
+53.10%
-1.23
-146.71%
2.64
Change In Account Payable
1.82
+413.62%
-0.58
+53.10%
-1.23
-146.71%
2.64
Investing Cash Flow
-0.12
0.00
0.00
-100.00%
0.00
Cash Flow From Continuing Investing Activities
-0.12
0.00
0.00
-100.00%
0.00
Net PPE Purchase And Sale
-0.12
0.00
—
—
Purchase Of PPE
-0.12
0.00
—
—
Capital Expenditure
-0.12
—
—
—
Net Other Investing Changes
—
—
—
0.00
Financing Cash Flow
8.74
-11.57%
9.88
+12.85%
8.76
-0.11%
8.77
Cash Flow From Continuing Financing Activities
8.74
-11.57%
9.88
+12.85%
8.76
-0.11%
8.77
Net Issuance Payments Of Debt
0.00
+100.00%
-0.49
-180.14%
0.61
-90.12%
6.13
Issuance Of Debt
—
0.00
-100.00%
1.61
-78.69%
7.53
Repayment Of Debt
0.00
+100.00%
-0.49
+51.49%
-1.00
+28.98%
-1.41
Long Term Debt Issuance
—
0.00
-100.00%
1.61
-78.69%
7.53
Long Term Debt Payments
0.00
+100.00%
-0.49
+51.49%
-1.00
+28.98%
-1.41
Net Long Term Debt Issuance
0.00
+100.00%
-0.49
-180.14%
0.61
-90.12%
6.13
Net Common Stock Issuance
1.10
-34.13%
1.67
-81.55%
9.05
+139.21%
3.78
Proceeds From Stock Option Exercised
4.77
-54.71%
10.54
0.00
0.00
Net Other Financing Charges
-1.11
+39.76%
-1.84
-104.62%
-0.90
+21.29%
-1.14
Changes In Cash
0.81
-66.02%
2.38
+217.51%
-2.02
+77.80%
-9.12
Beginning Cash Position
3.50
+211.68%
1.12
-64.30%
3.15
-74.34%
12.26
End Cash Position
4.31
+23.08%
3.50
+211.68%
1.12
-64.30%
3.15
Free Cash Flow
-7.93
-5.69%
-7.50
+30.40%
-10.78
+39.73%
-17.89
Income Tax Paid Supplemental Data
0.00
-21.88%
0.00
+0.00%
0.00
+100.00%
0.00
Common Stock Issuance
1.10
-34.13%
1.67
-81.55%
9.05
+139.21%
3.78
Issuance Of Capital Stock
5.08
+203.89%
1.67
-81.55%
9.05
+139.21%
3.78
Net Preferred Stock Issuance
3.98
0.00
—
—
Preferred Stock Issuance
3.98
0.00
—
—
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category